<< Back to News

System Formulary Update
Stimulant Class Standardization
April 29, 2025

Situation: The Stimulants for ADHD class review and formulary standardization was approved at the April 2025 System Pharmacy and Therapeutics Committee meeting

Background: The following medications were reviewed: amphetamine, dexmethylphenidate, dextroamphetamine, dextroamphetamine/amphetamine, lisdexamfetamine, methylphenidate 

Assessment/Recommendations: System P&T voted to include the following products on the UNC Health Medication Formulary: 

• Dexmethylphenidate 5 mg tablets 

•  

  Dexmethylphenidate 5 mg ER capsule 

•  

  Dexmethylphenidate 10 mg ER capsule 

•  

  Dextroamphetamine/amphetamine 5 mg ER capsule 

•  

  Dextroamphetamine/amphetamine 10 mg ER capsule 

•  

  Dextroamphetamine/amphetamine 5 mg tablet 

•  

  Dextroamphetamine/amphetamine 10 mg tablet 

•  

  Dextroamphetamine/amphetamine 20 mg tablet

•  

  Lisdexamfetamine 20 mg capsule

•  

  Lisdexamfetamine 30 mg capsule

•  

  Methylphenidate 5 mg tablet 

•  

  Methylphenidate 10 mg tablet 

•  

  Methylphenidate 18 mg/24h tablet 

•  

  Methylphenidate 27 mg/24h tablet 

•  

  Methylphenidate 36 mg/24h tablet 

•  

  Methylphenidate 5 mg/mL suspension 

Note: Stock of these formulary products may vary at individual entities 

Formulary/Epic Changes will Go-Live on Tuesday, June 10